Cleveland Clinic Taussig Cancer Institute

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

2025 Breast Cancer Update: Review of Breast Cancer Symposia
2024 ASH Review
10th Annual Multidisciplinary Colorectal Oncology Course
2024 Management of Checkpoint Inhibitor-Related Toxicity
8th Annual Cleveland Breast Cancer Summit
2023 ASH Review
2023 Breast Cancer Update: Review of Breast Cancer Symposia
2023 Management of Checkpoint Inhibitor-Related Toxicity
2022 Management of Checkpoint Inhibitor-Related Toxicities
2022 Breast Cancer Update: Review of Breast Cancer Symposium
2021 Management of Checkpoint Inhibitor-Related Toxicity
Breast Cancer Update: Review of Breast Cancer Symposia
7th Annual Multidisciplinary Colorectal Oncology Course
ASCO 2020 Highlights
20th Annual ASH Review
Benign Hematology Malignant Hematology
2020 Management of Checkpoint Inhibitor-Related Toxicity
Common but Complex irAEs It Isn’t Just Joint Pain Common and Emergent irAEs Rare and Fatal irAEs
2020 Multidisciplinary Head and Neck Cancer Update
HPV/Oropharynx/Re-treatment/Personalized Radiotherapy/Value-based Care Oral Cavity/Melanoma/Non-melanoma Skin Larynx/Thyroid Salivary Gland/Paranasal Sinus/Parapharyngeal Space Tumors/QOL/Immunotherapy
6th Annual Multidisciplinary Colorectal Oncology Course
Rectal Cancer CRC in the Young Patient Survivorship Metastatic Colon Cancer
5th Annual Cleveland Breast Cancer Summit
Breast Cancer Management Breast Cancer Cases
5th Annual Multidisciplinary Colorectal Oncology Course
Breast
GI
GU
Skin
Lymphoma
Leukemia
Lung
Gyn
MDS and MPN
Benign Hematology
Myeloma
Hematologic Malignancies
Events
Updates in Melanoma and High Risk Skin Cancer Management

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Diagnosis and Management of Ophthalmic Complications of Checkpoint Inhibitors in 2024

By Cleveland Clinic Taussig Cancer Institute FEATURING Sumit Sharma

12 views

September 26, 2024

Comments 0

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

2024 Management of Checkpoint Inhibitor-Related Toxicity